1
项与 GPRC5D CART (Hadassah Medical Center) 相关的临床试验 / Not yet recruiting临床1期IIT A Phase 1a/b Open-Label Study to Evaluate Safety and Preliminary Efficacy of GPRC5D CART Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma and Light-chain Amyloidosis.
A Phase 1a/b Open-Label Study to Evaluate Safety and Preliminary Efficacy of GPRC5D CART Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma and Light-chain Amyloidosis.
100 项与 GPRC5D CART (Hadassah Medical Center) 相关的临床结果
100 项与 GPRC5D CART (Hadassah Medical Center) 相关的转化医学
100 项与 GPRC5D CART (Hadassah Medical Center) 相关的专利(医药)
100 项与 GPRC5D CART (Hadassah Medical Center) 相关的药物交易